Skip to content
healthcare.dev
Get a free key

Rinvoq

NDC 0074-2306, Upadacitinib, tablet, extended release, from AbbVie Inc..

Product NDC
0074-2306
Status
Listed
Labeler
AbbVie Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211675
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-2306 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • UPADACITINIB15 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0074-2306-300007423063030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-30)
0074-2306-700007423067014 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-70)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2966aec7-2ef0-923c-d8ff-fe1a957bf095

  • NADAC price for package 00074230630

    GET /v1/drugs/nadac/00074230630

Use it

Look up 0074-2306 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-2306 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-2306. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.